Skip to main content

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Reports on Q1 Financial, Corporate Results

Brain Scientific (OTCQB: BRSF), an innovative company focusing on the medical technology market, has released its financial and business report for first quarter 2022, the period ended March 31, 2022. Highlights of the report include the company’s announcement that its novel neurology products would be presented to the NATO Center of Excellence for Military Medicine as an innovative and potentially life-saving tool for armed service personnel; that it is partnering with CODICO GmBH to expand its reach into eastern Europe, including Poland, Austria, Hungary, Czech Republic and Slovakia; and that it is collaborating with Micro Technology Group, which will deliver BRSF’s  motion control and automation solutions to OEM manufacturers throughout the northeastern United States. In addition, the report noted that the company had named two senior executives to lead revenue generation efforts, hosted a webinar in March to discuss how miniature precision motors can be disruptive in the market, and released a whitepaper focused on the role of the company’s RAS rotary motor in the medical device and high-tech application markets. Other new agreements and partnerships the company announced first quarter include Benson Engineering, Motion & Control Sales, Electroline Sales Inc., Applied Mechatronics and STXi Motion. “2022 is off to a great start, as we’ve significantly expanded the distribution of our products domestically and worldwide and added highly accomplished and experienced senior personnel to lead revenue generation efforts,” said Brain Scientific chair and CEO Hassan Kotob in the press release. “We also recently announced the presentation of our neurology products to the NATO Center of Excellence for Military Medicine, further highlighting the potential of our innovative products. Looking ahead we will leverage our strong performance and momentum from Q1 to increase sales and drive shareholder value.”

To view the full press release, visit

About Brain Scientific Inc.

Brain Scientific is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap and NeuroEEG are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultraefficient compact precision motors that will drive the next generation of medical devices. To learn more about the company, visit

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.